Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from AFT Pharmaceuticals Ltd. ( (AU:AFP) ).
AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208,021,000 for the year ending March 31, 2025, but experienced a 23% decline in net profit to NZ$11,962,000. The company announced a dividend of $0.016 per equity security, reflecting its continued compliance with NZX and ASX listing rules.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Limited is a New Zealand-based company operating in the pharmaceutical industry. The company focuses on developing and distributing pharmaceutical products, catering to various market needs.
Average Trading Volume: 2,348
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$255.3M
See more data about AFP stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue